These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2145808)

  • 21. [A case of so-called benign metastasizing leiomyoma responsive to progesterone].
    Motegi M; Takayanagi N; Sando Y; Ubukata M; Imai S; Suzuki T; Nakajima T; Yoshida I
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Jul; 31(7):890-5. PubMed ID: 8366630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An overview of clinical trials with high-dose medroxyprogesterone acetate (HD-MPA) in endocrine-related tumors other than breast cancer.
    Robustelli della Cuna G; Zanon P; Pavesi L; Preti P; Prada GA; Decensi A
    Chemioterapia; 1986 Jun; 5(3):164-72. PubMed ID: 2941173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combined therapies with medroxyprogesterone acetate (MPA) in DMBA-induced rat mammary cancer].
    Ishikawa H; Iino Y; Izuo M; Takikawa H
    Gan No Rinsho; 1986 Feb; 32(2):151-5. PubMed ID: 2937941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medroxyprogesterone acetate: variation in serum concentrations achieved with three commercially available preparations.
    Stockdale AD; Chapman D; Mould GP; Rostom AY
    Cancer Treat Rep; 1987 Sep; 71(9):813-5. PubMed ID: 2957052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective effect of high-dose medroxyprogesterone acetate (HD-MPA) on hematological toxicity induced by chemotherapy for advanced solid tumors: a multicentric controlled clinical trial. MPA-Hematology Italian Cooperative Group.
    Chemioterapia; 1986 Apr; 5(2):134-9. PubMed ID: 2871945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose medroxyprogesterone acetate in patients with renal adenocarcinoma and measurable lung metastases: a phase II study.
    Kjaer M; Frederiksen PL
    Cancer Treat Rep; 1986 Mar; 70(3):431-2. PubMed ID: 2937534
    [No Abstract]   [Full Text] [Related]  

  • 27. [Mammary gland carcinoma treated by large-dose medroxyprogesterone acetate of which pulmonary metastases disappeared and a selection of hormone, chemoimmunological treatment].
    Matsumoto S; Kutsuna T; Tann M; Mizuno Y; Shinohara M; Kimura T; Banno T; Yoshizaki S
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2457-9. PubMed ID: 2526619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The medroxyprogesterone acetate serum level following various medroxyprogesterone acetate dose schedules in gynecologic oncology].
    Husslein P; Egarter C; Eppel W; Salzer H; Spona J
    Zentralbl Gynakol; 1988; 110(20):1277-82. PubMed ID: 2977043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A case of bone and lung metastasis of breast cancer successfully treated with radiotherapy, chemotherapy and endocrine therapy].
    Kanda K; Waki S; Uchimura M; Kida H; Narita K; Harada N
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2421-4. PubMed ID: 2260877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medroxyprogesterone acetate at very high doses in postmenopausal advanced breast cancer patients.
    Pannuti F; Longhi A; Martoni A; Piana E; Baroni M
    Chemioterapia; 1987 Dec; 6(6):396-8. PubMed ID: 2963702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [High dose medroxyprogesterone acetate in metastatic breast cancer. Comparative clinical, pharmacokinetic and pharmacodynamic data of different forms of administration].
    Blossey HC; Wander HE; Nagel GA; Köbberling J; Kleeberg U
    Onkologie; 1982 Aug; 5 Suppl():13-6. PubMed ID: 6215599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of antitumoral activity of medroxyprogesterone acetate for endometrial cancer.
    Fujimoto J; Fujita H; Hosoda S; Okada H
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1836-40. PubMed ID: 2531782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of medroxyprogesterone acetate on side effects of CAP therapy in gynecological malignant tumors].
    Yanagawa Y; Okazaki T; Okamura S; Ueki M; Sugimoto O
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2393-8. PubMed ID: 2526618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ACTH and cortisol plasma levels in cancer patients treated with medroxyprogesterone acetate at high dosages.
    Papaleo C; Carella C; Zito GA; Figlia A; Capuano F; Amato G
    Chemioterapia; 1984 Aug; 3(4):220-2. PubMed ID: 6099752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of high-dose medroxyprogesterone acetate in advanced breast cancer, with special reference to prior endocrine therapy and hormone receptors].
    Nomura Y; Tashiro H; Hisamatsu K; Toi M
    Gan To Kagaku Ryoho; 1988 Mar; 15(3):513-8. PubMed ID: 2964811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of dural sinus thrombosis during the medication of medroxyprogesterone acetate].
    Hitosugi M; Kitamura O; Takatsu A; Watanabe K; Kan S
    Nihon Hoigaku Zasshi; 1997 Dec; 51(6):452-6. PubMed ID: 9545761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medroxyprogesterone acetate and lipid metabolic changes.
    Teichmann AT; Wander HE; Cremer P; Wieland H; Kuhn W; Nagel GA; Seidel D
    Arzneimittelforschung; 1987 May; 37(5):573-7. PubMed ID: 2956958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Response of estrogen and progesterone receptors to treatment with large doses of progestogen (depo-provera) in endometrial cancer].
    Thurzó L
    Zentralbl Gynakol; 1990; 112(17):1111-5. PubMed ID: 2148245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy with progestins and tamoxifen in advanced breast cancer: A preliminary report.
    Trodella L; Ausilli-Cefaro GP; Turriziani A; Saccheri S; Venturo I; Minotti G
    Am J Clin Oncol; 1982 Oct; 5(5):495-9. PubMed ID: 6217741
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experimental study of the treatment of uterine leiomyosarcoma in the mouse with progestogen].
    Sato Y; Tanaka K; Arakawa O; Ono M; Hirohashi T; Obata N; Takeuchi S
    Gan No Rinsho; 1988 Nov; 34(14):1979-84. PubMed ID: 2974492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.